Page 106 - MemoriaES-Eng

RESEARCH GROUPS

áá
í
í

ó
áó
é
Á

í
ó

í

áú
éú

PROGRAMME:
Group 4
COPD/ Sleep Apnea/

Lung Cancer
á

Group Members
Lead Researcher

óSTAFF MEMBERS
Gonzlez Mangado, Nicolás

Fernndez Arias, Jos
Pelcano Vizuete, Sandra
Contact:
í
Prez Rial, Sandra
Servicio de Neumologa. Instituto de Investigacion é
Sanitaria - Fundacion Jimnez Díaz. ASSOCIATED MEMBERS
Fernndez Ormaechea, Itziar
Avda. Reyes Catlicos, 2. Madrid · Phone: (+34) 91 550 49 12
E.mail: [email protected] Girn Martnez, Alvaro

http://www.fjd.es/es/cartera-servicios/especialidades-medicas/neumologia
Heili Frades, Sara Beatriz
Peces-Barba Romero, Germn

Rodrguez Nieto, Mara Jess
Seijo Maceiras, Luis Miguel Main lines of research

Surez Sipmann, Fernando
Terrn Expsito, Ral • CRP OF SLEEP APNEA: OSA as a risk factor for cardiovascular morbidity
and mortality, OSA as a risk factor for cancer and SAHS in women.
Villar lvarez, Felipe

• CRP OF CANCER: Early detection program in subjects at high risk for
emphysema or lung function impairment. Risk of each individual as his

smoking habit and personal and family history. Influence of associated
diseases, especially chronic obstructive pulmonary disease (COPD) and
13
emphysema over the risk of developing lung cancer and its prognosis. 20
T
Genetic and molecular factors that determine the risk profile of each indi- R
vidual.
PO
E
• CRP OF COPD: Susceptibility to the development of lung injury and its L R
A
evolution up to present the well established disease in animal models. NU
N
Identification of the key biomarkers in the development and progression A
of the disease and its translation to the clinic. Cohorts of COPD patients /
ES
with early onset and with late-stage severe COPD. New therapeutic targets ER
based on the utilization of growth factors in experimental models of disea- B
CI
se and in endoscopic implantation in patients of spirals and valves for the

106
treatment of emphysema .